Myocardial Infarction

Results of the TATORT-NSTEMI trial presented

According to a new study, aspirating blood clots does not significantly reduce microvascular obstruction or reduce the risk of death in patients with non-ST-elevation myocardial infarction (NSTEMI), when compared to standard ...

Nov 01, 2013
popularity not rated yet | comments 0

Results of the GIANT trial reported

According to a new study, genetic profiling of patients undergoing percutaneous coronary intervention (PCI) may help cardiology teams adjust treatment and improve ischemic outcomes for patients that do not properly metabolize ...

Nov 01, 2013
popularity not rated yet | comments 0

Results of the TRANSLATE-POPS trial presented

According to a new study of heart attack patients treated with percutaneous coronary intervention (PCI), free access to platelet function testing had only a modest impact on anti-clotting drug selection and dosing. Findings ...

Oct 31, 2013
popularity not rated yet | comments 0

Results of the HYBRID trial presented

A hybrid approach to treating coronary artery disease that involves a "hybrid procedure" combining a minimally invasive bypass surgery with percutaneous coronary intervention (PCI) was found to be feasible and safe in a clinical ...

Oct 31, 2013
popularity not rated yet | comments 0

Results of the FREEDOM sub study reported

According to a recent study of diabetic patients who underwent revascularization for multi-vessel coronary artery disease (CAD), patients treated with insulin experienced more major adverse cardiovascular events after revascularization ...

Oct 31, 2013
popularity not rated yet | comments 0

Results of DUTCH PEERS (TWENTE II) trial reported

Results of the DUTCH PEERS (TWENTE II) clinical trial demonstrate comparable safety and efficacy of two third-generation permanent polymer-based drug-eluting stents with low rates of adverse clinical events and establish ...

Oct 31, 2013
popularity not rated yet | comments 0

Results of the ARCTIC-INTERRUPTION trial presented

According to a new study, patients that do not experience a major cardiac event in the first year after receiving drug-eluting stent (DES) may not need to receive prolonged dual antiplatelet therapy (DAPT). Results from the ...

Oct 31, 2013
popularity not rated yet | comments 0

Results of the OPTIMIZE trial presented

A new study demonstrates that some patients may not need to receive prolonged anti-clotting therapy after drug-eluting stent (DES) implantation with the Endeavor zotarolimus-eluting stent, and that shortening the duration ...

Oct 31, 2013
popularity not rated yet | comments 0

Latest Spotlight News

Discovery could lead to new cancer treatment

A team of scientists from the University of Colorado School of Medicine has reported the breakthrough discovery of a process to expand production of stem cells used to treat cancer patients. These findings could have implications ...

HIV lessons from the Mississippi Baby

(Medical Xpress)—The news in July that HIV had returned in a Mississippi toddler after a two-year treatment-free remission dashed the hopes of clinicians, HIV researchers and the public at large tantalized ...

Mutation disables innate immune system

A Ludwig Maximilian University of Munich team has shown that defects in the JAGN1 gene inhibit the function of a specific type of white blood cells, and account for a rare congenital immune deficiency that ...